ATC Group: C01DA14 Isosorbide mononitrate

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C01DA14 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C01 Cardiac therapy
3 C01D Vasodilators used in cardiac diseases
4 C01DA Organic nitrates
5 C01DA14 Isosorbide mononitrate

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code Route Amount Notes
ORAL Oral 40 mg

Active ingredients in C01DA14

Active Ingredient

Isosorbide mononitrate is an organic nitrate, which, in common with other cardioactive nitrates, is a vasodilator. It produces decreased left and right ventricular end-diastolic pressures to a greater extent than the decrease in systemic arterial pressure, thereby reducing afterload and especially the preload of the heart.

Related product monographs

Document Type Information Source  
 CARMIL XL Prolonged release tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ELANTAN LA Prolonged release capsule MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ISMO Retard prolonged-release tablet MPI, EU: SmPC Medicines and Medical Devices Safety Authority (NZ)
 ISOMONIT Prolonged release tablet MPI, EU: SmPC Health Products Regulatory Authority (IE)
 ISOSORBIDE MONONITRATE / CARMIL / MONOMIL Tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 MONOREM Prolonged-release tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 MONOREM Tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 NYZAMAC Prolonged-release capsule, hard MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

United States medicines

Medicines classified under this ATC code globally

Albania (AL)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.